Description
JARDIAN-BEXIMCO 25MG: Optimize your health management with Jardian-Beximco 25mg, a powerful medication for adults with Type 2 Diabetes Mellitus and co-existing cardiovascular or renal conditions. Each tablet contains Empagliflozin 25mg, a potent Sodium-Glucose Cotransporter-2 (SGLT2) inhibitor. This advanced medication effectively lowers blood sugar by increasing glucose excretion through the kidneys. Beyond its role in glycemic control, Jardian-Beximco 25mg is clinically proven to significantly reduce the risk of cardiovascular death and hospitalization in adults with heart failure, and to lower the risk of cardiovascular death in Type 2 Diabetes patients with established cardiovascular disease. Furthermore, it offers crucial benefits in reducing the risk of end-stage renal disease, cardiovascular death, and hospitalization in adults with chronic kidney disease. It is used as an essential adjunct to diet and exercise. Jardian-Beximco 25mg is a Prescription-Only Medicine (P.O.M.) and must only be dispensed with a valid prescription from a qualified healthcare professional.
